In one paragraphArticle in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
- Commented on by
- Comment on
5 · Who and what moneyAuthors and funding
4 authors.
Valerio NardoneValerio Nardone, MD, Department of Precision Oncology, University Hospital of Campania "L. Vanvitelli," Naples, Italy; Tomer Meirson, MD, Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel; Francesca De Felice, MD, Department of Radiotherapy, Policlinico Umberto I "Sapienza," University of Rome, Rome, Italy; and Icro Meattini, MD, Department of Experimental and Clinical Biomedical Sciences "M. Serio," University of Florence, Florence, Italy.ORCID 0000-0002-7347-0965 Tomer MeirsonValerio Nardone, MD, Department of Precision Oncology, University Hospital of Campania "L. Vanvitelli," Naples, Italy; Tomer Meirson, MD, Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel; Francesca De Felice, MD, Department of Radiotherapy, Policlinico Umberto I "Sapienza," University of Rome, Rome, Italy; and Icro Meattini, MD, Department of Experimental and Clinical Biomedical Sciences "M. Serio," University of Florence, Florence, Italy.ORCID 0000-0002-5011-5477 Francesca De FeliceValerio Nardone, MD, Department of Precision Oncology, University Hospital of Campania "L. Vanvitelli," Naples, Italy; Tomer Meirson, MD, Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel; Francesca De Felice, MD, Department of Radiotherapy, Policlinico Umberto I "Sapienza," University of Rome, Rome, Italy; and Icro Meattini, MD, Department of Experimental and Clinical Biomedical Sciences "M. Serio," University of Florence, Florence, Italy.ORCID 0000-0002-5119-8358 Icro MeattiniValerio Nardone, MD, Department of Precision Oncology, University Hospital of Campania "L. Vanvitelli," Naples, Italy; Tomer Meirson, MD, Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel; Francesca De Felice, MD, Department of Radiotherapy, Policlinico Umberto I "Sapienza," University of Rome, Rome, Italy; and Icro Meattini, MD, Department of Experimental and Clinical Biomedical Sciences "M. Serio," University of Florence, Florence, Italy.ORCID 0000-0002-1861-2895 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Gene Expression ProfilingGenomicsHigh-Throughput Nucleotide SequencingHumansMutationRetrospective Studies
What OpenQuestion holds
Textmetadata
Read underepoch 390